Ready for SDM- evaluation of an interprofessional training module in shared decision making - A cluster randomized trial

Patient Educ Couns. 2022 Jul;105(7):2307-2314. doi: 10.1016/j.pec.2022.03.013. Epub 2022 Mar 17.

Abstract

Objective: Ready for SDM was developed in Norway as a comprehensive modularized curriculum for health care providers (HCP). The current study evaluated the efficacy of one of the modules, a 2-hour interprofessional SDM training designed to enhance SDM competencies.

Methods: A cluster randomized controlled trial was conducted with eight District Psychiatric Centres randomized to wait-list control (CG) or intervention group (IG). Participants and trainers were not blinded to their allocation. The IG received a 2-hour didactic and interactive training, using video examples. The primary outcome was the agreement between the participants' and an expert assessment of patient involvement in a video recorded consultation. The SDM-knowledge score was a secondary outcome.

Results: Compared to the CG (n = 65), the IG (n = 69) judged involvement behavior in a communication example more accurately (mean difference of weighted T, adjusted for age and gender:=-0.098, p = 0.028) and demonstrated better knowledge (mean difference=-0.58; p = 0.014). A sensitivity analysis entering a random effect for cluster turned out not significant.

Conclusion: The interprofessional group training can improve HCPs' SDM-competencies.

Practice implications: Addressing interprofessional teams using SDM communication training could supplement existing SDM training approaches. More research is needed to evaluate the training module's effects as a component of large-scale implementation of SDM.

Keywords: Communication skills; Curriculum; Inter-professional Education; Randomized controlled trial; Shared decision-making.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminoacridines
  • Communication
  • Decision Making*
  • Decision Making, Shared*
  • Humans
  • Patient Participation

Substances

  • Aminoacridines
  • SDM

Associated data

  • ISRCTN/ISRCTN14184328